Effects of Electrical Baroreflex Stimulation on Sympathetic Activity, Renal Hemodynamics, and Insulin Sensitivity (CVRX-ReSy)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01355510|
Recruitment Status : Unknown
Verified September 2013 by Hannover Medical School.
Recruitment status was: Recruiting
First Posted : May 18, 2011
Last Update Posted : September 19, 2013
Electrical stimulation of carotid baroreceptors (baropacing) acutely decreases arterial pressure in patients with refractory hypertension. The reduction in blood pressure seems to be mediated through sympathetic inhibition with concomitant reduction in the activity of the renin-angiotensin system. Indeed, switching on and off the stimulation is accompanied by decreases and increases in central sympathetic vasoconstrictor outflow, respectively. Plasma renin concentration also decreases with acute electrical baroreflex stimulation.
In some patients chronic baropacing is associated with long-term blood pressure reduction.
However, there is sparse information as to the relative contribution of blood pressure regulating systems to account for the acute and chronic effects of baropacing. Sympathetic, renal, and vascular mechanisms are of special interest. Furthermore, technical aspects of electrical baroreflex stimulation may play a role, e.g. worsening of the electrical contact between the stimulating electrodes and the baroreceptor afferents.
This study is designed to answer the following primary questions:
- Does chronic electrical stimulation of carotid baroreceptors inhibit sympathetic vasoconstrictor tone also in the long-term?
- Does sympathetic vasoconstrictor tone increase on switching off chronic baropacing? Such an increase would confirm electrical integrity of the system and proper contact to the baroreceptor afferents.
- Does acute electrical baroreflex stimulation decrease renal vascular resistance?
- Does acute electrical baroreflex stimulation influence glucose delivery to skeletal muscle and change insulin sensitivity? The study follows an open-label observational design and it is planned to recruit up to 30 patients over 3 years.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Electrical Baroreflex Stimulation - Sympathetic Activity|
|Study Start Date :||January 2011|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01355510
|Contact: Jordan Jens, MDfirstname.lastname@example.org|
|Contact: Reuter Julia, MDemail@example.com|
|Hannover Medical School||Recruiting|
|Contact: Jens Jordan, MD +495115322821 firstname.lastname@example.org|
|Principal Investigator: Jens Jordan, MD|
|Sub-Investigator: Julia Reuter, MD|
|Sub-Investigator: Karsten Heusser, MD|